Creative Medical Technology Holdings, Inc. Shareholders' Equity
Creative Medical Technology Holdings, Inc. (CELZ) had Shareholders' Equity of $8.65 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $8.65M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.11M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $7.51M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $5.59M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $8.65M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $6.11M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $7.51M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $5.59M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $6.83M 10-Q · filed 2025-11-07 | |
| 2025-03-31 | $8.06M 10-Q · filed 2025-08-08 | |
| 2024-12-31 | $6.34M 10-K · filed 2026-03-20 | |
| 2024-09-30 | $6.56M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $7.61M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $9.23M 10-Q · filed 2025-08-08 | |
| 2023-12-31 | $10.34M 10-Q · filed 2025-11-07 | |
| 2023-09-30 | $12.09M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $13.73M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $14.82M 10-Q · filed 2024-08-09 | |
| 2022-12-31 | $15.86M 10-K · filed 2025-03-14 | |
| 2022-09-30 | $22.07M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $23.04M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $9.35M 10-Q · filed 2023-08-11 | |
| 2021-12-31 | $10.22M 10-K · filed 2024-03-22 | |
| 2021-09-30 | -$363.35K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$714.45K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | -$2.44M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | -$39.80M 10-K · filed 2023-03-31 | |
| 2020-09-30 | -$2.78M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$4.20M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | -$3.18M 10-Q · filed 2021-08-16 | |
| 2019-12-31 | -$8.07M 10-K · filed 2022-03-30 | |
| 2019-09-30 | -$3.56M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | -$2.64M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | -$3.60M 10-Q · filed 2020-08-14 | |
| 2018-12-31 | -$3.99M 10-K · filed 2021-03-17 | |
| 2018-09-30 | -$7.35M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$10.59M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | -$7.93M 10-Q · filed 2019-08-13 | -$7.93M 10-Q · filed 2019-05-20 |
| 2017-12-31 | -$2.24M 10-K · filed 2020-04-06 | |
| 2016-12-31 | -$157.79K 10-K · filed 2019-04-01 | |
| 2015-12-31 | $49.50K 10-K · filed 2018-03-29 | -$183.80K 10-K · filed 2016-04-14 |
| 2015-12-29 | $0.00 10-K · filed 2017-02-13 | |
| 2014-12-31 | -$153.04K 10-K · filed 2016-04-14 | |
| 2013-12-31 | -$125.03K 10-K · filed 2016-04-14 | |
| 2012-12-31 | -$97.75K 10-K · filed 2015-02-27 | |
| 2012-09-30 | -$91.76K 10-Q · filed 2012-11-07 | |
| 2012-03-31 | -$81.22K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$72.16K 10-K · filed 2014-03-17 | |
| 2011-09-30 | -$65.36K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | -$60.76K 10-Q/A · filed 2011-08-25 | |
| 2010-12-31 | -$48.11K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |